Study guide
5.6 Antimicrobial Resistance, Susceptibility Testing, Specimen Handling & Vaccines
APMLE Part I Basic Sciences Podiatry
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Overview & Lower Extremity Osteology
1.1 APMLE Part I Exam Structure, Policies & Scoring 1.2 Foot Osteology: Tarsals, Metatarsals, Phalanges & Sesamoids 1.3 Leg & Ankle Osteology: Tibia, Fibula & The Ankle Mortise 1.4 Pelvis, Femur & Patella Osteology: Landmarks & Biomechanics
2 Chapter 2: Lower Extremity Arthrology & Ligaments
2.1 Foot Articulations: Subtalar, Midtarsal, Lisfranc & Digital Joints 2.2 Talocrural (Ankle) & Knee Joints: Ligaments & Kinematics 2.3 Hip Joint & Pelvic Articulations: Capsular Structures & Dynamics
3 Chapter 3: Lower Extremity Myology & Compartments
3.1 Anterior & Lateral Compartments of the Leg 3.2 Superficial & Deep Posterior Compartments of the Leg 3.3 Plantar Layers & Intrinsic Musculature of the Foot 3.4 Thigh & Gluteal Musculature: Attachments & Innervations
4 Chapter 4: Lower Extremity Neurovascular & Topographical Anatomy
4.1 Lumbar & Sacral Plexuses, Peripheral Nerves & Dermatomes 4.2 Arterial Network, Venous Drainage & Lymphatics 4.3 Tarsal Tunnel, Femoral Triangle & Topographical Spaces
5 Chapter 5: Microbiology: Bacteriology, Zoonoses & Laboratory Methods
5.1 Gram-Positive Cocci & Bacilli in Podiatric Infections 5.2 Gram-Negative Bacilli & Opportunistic Pathogens 5.3 Anaerobic Pathogens & Diabetic Foot Infections 5.4 Bacterial Structure, Virulence Factors & Sterilization 5.5 Mycobacteria, Spirochetes, Mycoplasma & Zoonotic Infections 5.6 Antimicrobial Resistance, Susceptibility Testing, Specimen Handling & Vaccines
6 Chapter 6: Mycology, Virology, Parasitology & Clinical Immunology
6.1 Mycology: Dermatophytes, Onychomycosis & Systemic Mycoses 6.2 Clinically Relevant Viruses & Parasitic Infections 6.3 Innate & Adaptive Immunity Mechanisms 6.4 Hypersensitivity Reactions, Immunodeficiencies & Autoimmunity 6.5 Transplant & Tumor Immunology and Immunodiagnostic Methods
7 Chapter 7: General & Cellular Pathology
7.1 Cellular Injury, Adaptations & Cell Death Mechanisms 7.2 Acute vs Chronic Inflammation & Tissue Repair 7.3 Hemodynamic Disorders, Thrombosis, Embolism & Shock 7.4 Neoplasia, Oncogenes, Tumor Suppressors & Cutaneous Tumors
8 Chapter 8: Systemic & Podiatric Pathology
8.1 Atherosclerosis, Peripheral Artery Disease & Diabetic Microangiopathy 8.2 Osteoarthritis, Inflammatory Arthritides & Bone Infections 8.3 Neuropathic Disorders, Charcot Neuroarthropathy & Dermatopathology 8.4 Laboratory Diagnostics, Synovial Fluid & Biopsy Interpretation
9 Chapter 9: Organ-System Pathology
9.1 Anemias, Hemoglobinopathies, Leukemias & Immune Disorders 9.2 Cardiac & Pulmonary Pathology 9.3 Renal, Urogenital & Reproductive Pathology 9.4 Gastrointestinal, Hepatobiliary & Endocrine Pathology
10 Chapter 10: General Pharmacology, Autonomic Drugs & Toxicology
10.1 Pharmacokinetics, ADME & Receptor Dynamics 10.2 Cholinergic Agonists & Muscarinic/Nicotinic Antagonists 10.3 Adrenergic Agonists, Sympatholytics & Clinical Applications 10.4 Cardiovascular Pharmacology in Podiatric Patients 10.5 Drug Interactions, Adverse Effects, Pharmacogenomics & Toxicology
11 Chapter 11: Antimicrobial & Podiatric Therapeutics
11.1 Antibacterial Classes, Mechanisms & Resistances 11.2 Antifungal, Antiviral & Antiparasitic Therapeutics 11.3 NSAIDs, Opioids, Corticosteroids & Anti-Gout Agents 11.4 Local & General Anesthetic Pharmacology
12 Chapter 12: Systemic Pharmacology
12.1 Anticonvulsants, Antidepressants, Psychotropics & Skeletal Muscle Relaxants 12.2 Insulin & Noninsulin Glycemic Agents 12.3 Respiratory & Gastrointestinal Agents 12.4 DMARDs, Biologics, Antineoplastics & Immunosuppressants 12.5 Hormone Therapy, Bisphosphonates, Antihistamines, Growth Factors & Complementary Agents
13 Chapter 13: General Anatomy: Systemic Gross Anatomy & Neuroanatomy
13.1 Cranial Nerves, Head & Neck Anatomy 13.2 Thoracic Wall, Tracheobronchial Tree, Lungs & Mediastinum 13.3 Abdominal Wall, GI Viscera, Pelvis & Retroperitoneum 13.4 Vertebral Column, Spinal Cord & Upper Extremity Overview 13.5 Neuroanatomy: CNS Organization, Somatosensory & Motor Pathways
14 Chapter 14: Histology, Integument, Embryology & Genetics
14.1 Microscopic Anatomy: Epithelia, Connective Tissue, Muscle & Nerve 14.2 Integumentary System: Dermis, Appendages, Nail Unit & Cutaneous Receptors 14.3 Embryogenesis, Limb Morphogenesis & Postnatal Development 14.4 Medical Genetics & Structural Alterations in Aging
15 Chapter 15: Cellular, Neuromuscular & Cardiovascular Physiology
15.1 Membrane Potential, Ion Channels & Transport Mechanisms 15.2 Action Potentials, Synaptic Transmission & Muscle Contraction 15.3 Cardiac Electrophysiology, ECG & Hemodynamics 15.4 Blood Pressure Regulation, Poiseuille Law & Capillary Dynamics
16 Chapter 16: Organ-System Physiology: Respiratory, Renal, Endocrine, GI & Blood
16.1 Pulmonary Mechanics, Gas Exchange & Acid-Base Regulation 16.2 Renal Filtration, Tubular Transport & Fluid/Acid-Base Balance 16.3 Endocrine Regulation, Reproductive Hormones, Calcium & Bone 16.4 Gastrointestinal & Hepatobiliary Physiology 16.5 Hematology: Erythropoiesis, Leukocytes, Platelets & Coagulation 16.6 Exercise Physiology, Thermoregulation & Bone Mechanobiology
17 Chapter 17: Biochemistry: Proteins, Enzymes, Carbohydrates & Signaling
17.1 Amino Acid Chemistry, Protein Structure & Enzyme Kinetics 17.2 Glycolysis, Gluconeogenesis, Glycogen Metabolism & TCA Cycle 17.3 Electron Transport Chain, ATP Synthesis & Metabolic Inborn Errors 17.4 Hormones, Receptors, Second Messengers & Signal Transduction
18 Chapter 18: Biochemistry: Lipids, Molecular Genetics, Blood Chemistry & Nutrition
18.1 Fatty Acid Oxidation, Ketogenesis, Cholesterol & Lipoproteins 18.2 Nucleotide Metabolism, DNA Replication, Transcription, Translation & Repair 18.3 Vitamins, Micronutrients & Inborn Errors of Metabolism 18.4 Blood Chemistry: Heme Metabolism, Hemoglobin & Plasma Proteins 18.5 Nutrition: Energy Balance, Glycemic Index, Fed-Fast Cycle & Free Radicals
5.6 Antimicrobial Resistance, Susceptibility Testing, Specimen Handling & Vaccines
Key Takeaways Explain This Topic AI
Bacteria resist antibiotics by enzymatic inactivation, target alteration, reduced porin entry, efflux pumps or bypass pathways, and they spread resistance genes horizontally by conjugation, transformation and transduction.
The minimum inhibitory concentration (MIC) is the lowest drug concentration that prevents visible growth; larger disk-diffusion zones correspond to lower MICs, and breakpoints convert an MIC into susceptible, intermediate or resistant.
A D-shaped zone of inhibition on the D-test identifies inducible clindamycin resistance (erm methylation) in an erythromycin-resistant staphylococcus.
For diabetic foot infection, cultures should come from debrided deep tissue or bone, not superficial swabs, and tissue for culture must never be placed in formalin.
Live attenuated vaccines generally are avoided in pregnancy and significant immunosuppression, whereas inactivated, subunit, toxoid, conjugate and mRNA vaccines cannot cause the infection they prevent.
Last updated: October 2026
5.6 Antimicrobial Resistance, Susceptibility Testing, Specimen Handling & Vaccines
The microbiology outline groups emerging drug resistance (mechanisms and susceptibility testing), laboratory testing (principles, specimen collection and handling, culture and sensitivity) and infection prevention and treatment (sterilization, antimicrobials and vaccines). Sterilization is covered in 5.4 and individual antibiotic classes in 11.1; this section ties those topics to how resistance develops and how a result reaches the chart.
Mechanisms of Antimicrobial Resistance
Mechanism Example Clinical consequence
Enzymatic inactivation Penicillinase ( blaZ ) in staphylococci; extended-spectrum beta-lactamases (ESBLs, often CTX-M) in E. coli and Klebsiella ; carbapenemases (KPC, NDM, OXA-48); aminoglycoside-modifying enzymes ESBL producers need a carbapenem or another active agent; carbapenemase producers are often multidrug resistant
Target alteration mecA -encoded PBP2a (MRSA); vanA D-Ala-D-Lac precursors (VRE); erm methylation of 23S rRNA; gyrA / parC point mutations; rpoB mutations Loss of an entire drug class, for example all conventional beta-lactams in MRSA
- Reduced entry Loss of the OprD porin in Pseudomonas aeruginosa Carbapenem (imipenem) resistance
- Efflux pumps MexAB-OprM in Pseudomonas ; tet pumps Multidrug or tetracycline resistance
- Bypass pathways Acquired sul or dfr genes encoding drug-insensitive folate enzymes TMP-SMX resistance
How resistance spreads. Spontaneous chromosomal mutations are passed vertically to daughter cells and are selected when antibiotic exposure kills susceptible neighbors. Horizontal gene transfer moves resistance between bacteria:
Conjugation: transfer of plasmids through a sex pilus, the main route for ESBL and carbapenemase genes.
Transformation: uptake of free DNA from lysed bacteria.
Transduction: transfer by bacteriophages.
Transposons and integrons: mobile elements that collect several resistance genes into one transferable unit.
Tolerance is not resistance. Bacteria inside biofilms on hardware or sequestra and dormant persister cells survive drug concentrations that kill free-floating (planktonic) cells of the same strain. They may still test susceptible in the laboratory. This is why chronic osteomyelitis and infected implants often need debridement or hardware removal.
Susceptibility Testing
Minimum inhibitory concentration (MIC): the lowest antibiotic concentration that prevents visible growth, usually measured by broth microdilution in twofold dilutions (0.5, 1, 2, 4 mcg/mL and so on).
Breakpoints: standard-setting bodies (CLSI in the United States and EUCAST in Europe) publish organism- and drug-specific cutoffs that classify an MIC as susceptible, intermediate (or susceptible-dose-dependent) or resistant. An MIC of 2 can be susceptible for one drug and resistant for another, so MIC numbers should not be compared across drugs.
Disk diffusion (Kirby-Bauer): an antibiotic disk on a lawn of bacteria creates a zone of inhibition. A larger zone means a lower MIC.
Gradient strips: a strip containing a continuous antibiotic gradient reads the MIC where the elliptical zone meets the strip.
D-test: an erythromycin disk is placed near a clindamycin disk. Flattening of the clindamycin zone into a "D" shape shows inducible MLSB (macrolide-lincosamide-streptogramin B) resistance from an erm gene. Clindamycin may fail during therapy even though the isolate initially looks clindamycin-susceptible.
MRSA detection: cefoxitin disk screening, PBP2a latex agglutination or mecA PCR.
Rapid identification: MALDI-TOF mass spectrometry identifies organisms from colonies within minutes, and multiplex PCR panels detect resistance genes ( mecA , vanA , KPC) directly from positive blood cultures.
Pharmacodynamic Targets
- Pattern Drugs Dosing logic
- Time-dependent killing Beta-lactams Maximize time above MIC (frequent dosing or extended infusion)
Concentration-dependent killing Aminoglycosides, fluoroquinolones, daptomycin Maximize peak/MIC or AUC/MIC (once-daily aminoglycoside dosing)
Exposure (AUC)-dependent Vancomycin Current guidance targets an AUC24/MIC of about 400–600 rather than trough levels alone
Specimen Collection, Handling & Culture
Laboratory results are only as good as the specimen:
Obtain specimens before antibiotics whenever the patient is stable. Two sets of blood cultures from separate sites are drawn when bacteremia is possible.
Diabetic foot infection: cleanse and debride the wound, then submit deep tissue obtained by curettage or biopsy . Superficial swabs of undebrided ulcers mostly grow colonizers and are discouraged.
Osteomyelitis: bone biopsy (percutaneous or surgical, ideally through intact skin) gives the most reliable microbiology and allows histology. After resection, a proximal "clean margin" bone specimen helps decide whether residual infection remains.
Separate the specimens: tissue for culture goes in a sterile container (with sterile saline if needed) ; tissue for histology goes in formalin. Formalin kills organisms and makes culture impossible.
Anaerobes: use anaerobic transport media or tissue rather than dry swabs, and deliver promptly.
Special requests: mycobacterial (AFB) and fungal cultures must be ordered specifically and can take weeks (up to 6–8 weeks for AFB).
Interpretation: a Gram stain showing many neutrophils with one organism type supports true infection. One positive blood culture for coagulase-negative staphylococci out of two sets usually indicates skin contamination.
- Infection Prevention, Surgical Prophylaxis & Vaccines
- Prevention in Practice
Hand hygiene: alcohol-based rub for most encounters; soap and water when hands are visibly soiled or for Clostridioides difficile , because alcohol does not kill spores.
Standard precautions for all patients; contact precautions for MRSA, VRE, multidrug-resistant gram-negatives and C. difficile .
Surgical site infection bundle: weight-based cefazolin (2 g for most adults, 3 g at or above 120 kg) given within 60 minutes before incision and redosed after about 4 hours or after major blood loss; hair clipping rather than shaving; alcohol-containing skin antisepsis such as chlorhexidine-alcohol; perioperative glucose control; normothermia.
Vaccine Types
Type Examples Key point
Live attenuated MMR, varicella, yellow fever, intranasal influenza Strong cellular and humoral immunity; generally contraindicated in pregnancy and significant immunosuppression
Inactivated whole organism Injectable influenza (most), inactivated polio, hepatitis A Usually needs boosters
Subunit or recombinant Hepatitis B , HPV, recombinant zoster vaccine Cannot cause infection; recombinant zoster vaccine can be used in immunocompromised adults
Toxoid Tetanus , diphtheria Antibodies neutralize the exotoxin (wound management in 5.3)
Conjugate Pneumococcal conjugate, Haemophilus influenzae type b, meningococcal Protein carrier converts a T-independent polysaccharide into a T-dependent antigen with memory
mRNA COVID-19 Host cells translate the encoded antigen
Healthcare personnel and hepatitis B. Podiatric clinicians perform sharp debridement and surgery, so they should complete a hepatitis B vaccine series and confirm protection with an anti-HBs titer of at least 10 mIU/mL . Vaccine eligibility and timing recommendations change, so check the current CDC schedules rather than memorizing a fixed calendar.